ライフサイエンスコーパス: gangrenosum

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 included pathergy, cystic acne, and pyoderma gangrenosum.

2 e discussed regarding psoriasis and pyoderma gangrenosum.

3 cers with a clinical resemblance to pyoderma gangrenosum.

4 and pretibial lesions diagnosed as pyoderma gangrenosum.

5 itides such as Sweet's syndrome and pyoderma gangrenosum.

6 patient presenting with aggressive pyoderma gangrenosum.

7 confirmed the clinical suspicion of pyoderma gangrenosum.

8 ing of a disease locus for familial pyoderma gangrenosum-acne-arthritis to the long arm of chromosome

9 h cutaneous manifestations, such as pyoderma gangrenosum and acne fulminans, predominated.

10 and less frequently accompanied by pyoderma gangrenosum and acne.

11 mmatory disease; pyogenic arthritis pyoderma gangrenosum and acne; Muckle-Wells syndrome; familial co

12 ents with Sweet's syndrome (SW) and pyoderma gangrenosum and found numerous novel splice variants in

13 s of PSTPIP1 in the pathogenesis of pyoderma gangrenosum and suggest that the cytoskeleton is a ratio

14 case of CB, initially diagnosed as pyoderma gangrenosum and treated with steroids, leading to dissem

15 Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (OMIM 604416) is a

16 disease called pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome.

17 the syndrome of pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA), a dominantly inherited aut

18 Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome (PAPA syndrome) is an aut

19 n (MRST); and a pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA).

20 ome and pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome.

21 ndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne, OMIM #604416) and familial recurr

22 ndrome: pyogenic sterile arthritis, pyoderma gangrenosum, and acne.

23 57 consecutive patients treated for pyoderma gangrenosum at our institution (10 percent).

24 associated disease and suggest that pyoderma gangrenosum can be classified as a dynamical disease at

25 exclusion, and the misdiagnosis of pyoderma gangrenosum can result in substantial complications in p

26 Pyoderma gangrenosum, cystic acne, and aseptic arthritis are clin

27 er entities, CB may be mistaken for pyoderma gangrenosum due to overlap of findings on histopathologi

28 ts studied, 64 had been treated for pyoderma gangrenosum for a median of 10 months (range, 3 to 180).

29 utive patients treated for presumed pyoderma gangrenosum from 1984 through 1992.

30 enosum (PPG), an unusual variant of pyoderma gangrenosum, has been reported almost exclusively in pat

31 Here we report the first case of pyoderma gangrenosum in a patient with refractory celiac disease.

32 in all patients suspected of having pyoderma gangrenosum in order to rule out alternative diagnoses.

33 Pyoderma gangrenosum is a diagnosis of exclusion, and the misdiag

34 Pyoderma gangrenosum is an inflammatory neutrophilic dermatosis c

35 Pyoderma gangrenosum is associated with a concomitant systemic di

36 The misdiagnosis of pyoderma gangrenosum is not uncommon and exposes patients to risk

37 cers in the 64 patients treated for pyoderma gangrenosum, it was clear that those in 23 patients (36

38 that refractory celiac disease and pyoderma gangrenosum may be immunologically different.

39 d in all other patients with either pyoderma gangrenosum or SW, it was always associated with splice

40 A pyoderma gangrenosum patient exhibiting aberrant leukocyte traffi

41 Pyoderma Gangrenosum (PG) is a cutaneous condition, its diagnosis

42 Pyoderma gangrenosum (PG) is an important disease with significan

43 Peristomal pyoderma gangrenosum (PPG), an unusual variant of pyoderma gangre

44 ot respond to treatment directed at pyoderma gangrenosum, those in 8 (12 percent) were exacerbated by

45 Good resolution of pyoderma gangrenosum was achieved in 3 patients with tumor necros

46 of 240 patients with a diagnosis of pyoderma gangrenosum who were evaluated at our institution from 1

47 y occurring, extra-hepatic onset of pyoderma gangrenosum, with the AIH in remission, strengthening th

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。